Quick Answer
Gonorrhea is the second most common reportable bacterial STI, with ~600,000 cases per year. It is curable with a single ceftriaxone injection, but antibiotic resistance is a growing concern. Most infections are asymptomatic.
- ~600,000 reported cases (CDC, 2023)
- Bacterial and curable
- Treatment: single ceftriaxone injection
- Antibiotic resistance is a top concern
Context Most Pages Skip
Gonorrhea has developed resistance to every antibiotic class used against it — ceftriaxone is the last reliable first-line agent.
Key Facts
Antibiotic-resistant strains are rising, making retesting after treatment important. The CDC recommends test-of-cure at 1-2 weeks.
⚕️ This page is educational and does not replace advice from a licensed clinician. If you may have been exposed to an STI, get tested — most infections are manageable, and many are fully curable.
Sources & Further Reading
- CDC — Sexually Transmitted Infections
- CDC STI Treatment Guidelines
- WHO — Sexually transmitted infections fact sheet
- MedlinePlus — Sexually Transmitted Diseases
Figures reflect CDC surveillance and WHO estimates; they are population statistics, not personal risk predictions.